CRISPR Therapeutics AG (LON:0VRQ)
56.15
-1.11 (-1.95%)
At close: Aug 1, 2025
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or -3.44% compared to the previous year.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$74,199
Profits / Employee
-$759,528
Market Cap
3.89B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 393 | -14 | -3.44% |
Dec 31, 2023 | 407 | -51 | -11.14% |
Dec 31, 2022 | 458 | -15 | -3.17% |
Dec 31, 2021 | 473 | 63 | 15.37% |
Dec 31, 2020 | 410 | 106 | 34.87% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
HSBC Holdings | 211,304 |
Shell | 96,000 |
Unilever | 115,964 |
Rolls-Royce Holdings | 42,400 |
British American Tobacco p.l.c. | 48,989 |
Rio Tinto Group | 60,000 |
RELX PLC | 36,400 |